DE60202203D1 - Neues verfahren zur herstellung von oxabispidinen - Google Patents

Neues verfahren zur herstellung von oxabispidinen

Info

Publication number: DE60202203D1
Authority: DE; Germany
Prior art keywords: sup; formula; compound; oxabispidines; production
Prior art date: 2001-04-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE2002602203

Other languages

English (en)

Other versions

DE60202203T2 (de

Inventor

Lal Cheema

David Cladingboel

Rhona Sinclair

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

AstraZeneca AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2002-04-12

Publication date

2005-01-13

2002-04-12 Application filed by AstraZeneca AB filed Critical AstraZeneca AB

2005-01-13 Publication of DE60202203D1 publication Critical patent/DE60202203D1/de

2005-12-15 Application granted granted Critical

2005-12-15 Publication of DE60202203T2 publication Critical patent/DE60202203T2/de

2022-04-13 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DE60202203T 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen Expired - Lifetime DE60202203T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0101324A SE0101324D0 (sv)	2001-04-12	2001-04-12	New process
SE0101324		2001-04-12
PCT/SE2002/000727 WO2002083690A1 (en)	2001-04-12	2002-04-12	New process for the preparation of oxabispidines

Publications (2)

Publication Number	Publication Date
DE60202203D1 true DE60202203D1 (de)	2005-01-13
DE60202203T2 DE60202203T2 (de)	2005-12-15

Family

ID=20283781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60202203T Expired - Lifetime DE60202203T2 (de)	2001-04-12	2002-04-12	Neues verfahren zur herstellung von oxabispidinen

Country Status (20)

Country	Link
US (2)	US7169921B2 (de)
EP (1)	EP1385850B1 (de)
JP (1)	JP4248880B2 (de)
KR (1)	KR100848613B1 (de)
CN (1)	CN1267435C (de)
AT (1)	ATE284405T1 (de)
AU (1)	AU2002249748B2 (de)
BR (1)	BR0208861A (de)
CA (1)	CA2443475A1 (de)
DE (1)	DE60202203T2 (de)
ES (1)	ES2233809T3 (de)
HK (1)	HK1060886A1 (de)
IL (2)	IL158249A0 (de)
MX (1)	MXPA03009211A (de)
NO (1)	NO20034526L (de)
NZ (1)	NZ528515A (de)
PT (1)	PT1385850E (de)
SE (1)	SE0101324D0 (de)
WO (1)	WO2002083690A1 (de)
ZA (1)	ZA200307676B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0101324D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	New process
GB0223712D0 (en)	2002-10-14	2002-11-20	Astrazeneca Ab	Chemical intermediate
US20040192738A1 (en) *	2003-03-18	2004-09-30	Aventis Pharma Deutschland Gmbh	2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
SE0401540D0 (sv) *	2004-06-15	2004-06-15	Astrazeneca Ab	New compounds
SE0401539D0 (sv) *	2004-06-15	2004-06-15	Astrazeneca Ab	New compounds
CN101243093A (zh) *	2005-06-13	2008-08-13	阿斯利康(瑞典)有限公司	用于治疗心律不齐的新型氧杂双哌啶化合物
US20090216002A1 (en) *	2005-06-16	2009-08-27	Girindus Ag	Synthesis of hydroquinone derivatives
AR057364A1 (es) *	2005-06-20	2007-11-28	Astrazeneca Ab	Proceso para el aislamiento de 4-(oxiranilmetoxi) -benzonitrilos
MX2007016498A (es) *	2005-06-20	2008-03-04	Astrazeneca Ab	Proceso para la preparacion de 3,7-dihidroxi-1,5-diazaciclooctanos .
AR053901A1 (es) *	2005-06-20	2007-05-23	Astrazeneca Ab	Formas fisicas de oxabispidinas n,n'- disustituidas
CA2610093A1 (en) *	2005-06-20	2006-12-28	Astrazeneca Ab	Process for the preparation of sulfonic acid salts of oxabispidines
CA2610205A1 (en) *	2005-06-20	2006-12-28	Astrazeneca Ab	Process for the production of (alkoxycarbonylamino)alkyl sulfonates
KR20080028435A (ko) *	2005-06-20	2008-03-31	아스트라제네카 아베	Ｎ,ｎ’-이치환된 옥사비스피딘의 제조 방법
SG10201802911RA (en)	2013-03-15	2018-05-30	Global Blood Therapeutics Inc	Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru)	2013-11-18	2020-06-30	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3196154A (en)	1962-05-17	1965-07-20	Sterling Drug Inc	3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US5110933A (en) *	1989-11-13	1992-05-05	Board Of Regents Of Oklahoma State University	Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) *	1997-12-17	1997-12-17	Astra Ab	Pharmaceutically active compounds
SE9903759D0 (sv)	1999-10-18	1999-10-18	Astra Ab	Pharmaceutically active compounds
SE0101324D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	New process

2001
- 2001-04-12 SE SE0101324A patent/SE0101324D0/xx unknown
2002
- 2002-04-12 BR BR0208861-4A patent/BR0208861A/pt not_active IP Right Cessation
- 2002-04-12 CN CNB028115759A patent/CN1267435C/zh not_active Expired - Fee Related
- 2002-04-12 CA CA002443475A patent/CA2443475A1/en not_active Abandoned
- 2002-04-12 AT AT02718766T patent/ATE284405T1/de not_active IP Right Cessation
- 2002-04-12 US US10/474,593 patent/US7169921B2/en not_active Expired - Fee Related
- 2002-04-12 ES ES02718766T patent/ES2233809T3/es not_active Expired - Lifetime
- 2002-04-12 IL IL15824902A patent/IL158249A0/xx unknown
- 2002-04-12 DE DE60202203T patent/DE60202203T2/de not_active Expired - Lifetime
- 2002-04-12 AU AU2002249748A patent/AU2002249748B2/en not_active Ceased
- 2002-04-12 NZ NZ528515A patent/NZ528515A/en unknown
- 2002-04-12 PT PT02718766T patent/PT1385850E/pt unknown
- 2002-04-12 EP EP02718766A patent/EP1385850B1/de not_active Expired - Lifetime
- 2002-04-12 KR KR1020037013158A patent/KR100848613B1/ko not_active IP Right Cessation
- 2002-04-12 JP JP2002581445A patent/JP4248880B2/ja not_active Expired - Fee Related
- 2002-04-12 WO PCT/SE2002/000727 patent/WO2002083690A1/en active IP Right Grant
- 2002-04-12 MX MXPA03009211A patent/MXPA03009211A/es active IP Right Grant
2003
- 2003-10-01 ZA ZA200307676A patent/ZA200307676B/en unknown
- 2003-10-02 IL IL158249A patent/IL158249A/en not_active IP Right Cessation
- 2003-10-09 NO NO20034526A patent/NO20034526L/no not_active Application Discontinuation
2004
- 2004-05-31 HK HK04103893A patent/HK1060886A1/xx not_active IP Right Cessation
2006
- 2006-12-19 US US11/612,826 patent/US20070197519A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US7169921B2 (en)	2007-01-30
CN1267435C (zh)	2006-08-02
EP1385850B1 (de)	2004-12-08
WO2002083690A1 (en)	2002-10-24
EP1385850A1 (de)	2004-02-04
KR20030087065A (ko)	2003-11-12
BR0208861A (pt)	2004-10-19
CA2443475A1 (en)	2002-10-24
NZ528515A (en)	2005-06-24
JP4248880B2 (ja)	2009-04-02
IL158249A0 (en)	2004-05-12
CN1520417A (zh)	2004-08-11
ZA200307676B (en)	2004-07-13
JP2004533432A (ja)	2004-11-04
KR100848613B1 (ko)	2008-07-28
IL158249A (en)	2009-09-01
US20040181060A1 (en)	2004-09-16
ATE284405T1 (de)	2004-12-15
PT1385850E (pt)	2005-03-31
DE60202203T2 (de)	2005-12-15
SE0101324D0 (sv)	2001-04-12
NO20034526D0 (no)	2003-10-09
US20070197519A1 (en)	2007-08-23
HK1060886A1 (en)	2004-08-27
AU2002249748B2 (en)	2008-02-28
MXPA03009211A (es)	2004-01-29
NO20034526L (no)	2003-10-31
ES2233809T3 (es)	2005-06-16

Similar Documents

Publication	Publication Date	Title
DE60202203D1 (de)	2005-01-13	Neues verfahren zur herstellung von oxabispidinen
DE602004025344D1 (de)	2010-03-18	Biologisch abbaubare verzweigte polylactidderivate, die zur bildung von polymermicellen befähigt sind, herstellungsverfahren dafür und verwendung davon
DE60233664D1 (de)	2009-10-22	Verfahren zur herstellung von pyridinverbindungen
DE60134472D1 (de)	2008-07-31	Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpone 17.beta.-karbonsäure
DE69915713D1 (de)	2004-04-22	Verfahren zur herstellung von citalopram
DE60219501D1 (de)	2007-05-24	Verfahren zur herstellung von 3-hydroxy-n-1,6-trialkyl-4-oxo-1,4-dihydropyridin-2-carboxamide
DE50113943D1 (de)	2008-06-19	4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
ATE266618T1 (de)	2004-05-15	Verfahren zur herstellung von zwischenprodukten für pestizide
ATE302749T1 (de)	2005-09-15	Verfahren zur herstellung von 5-aminosalicylsäure
ATE299851T1 (de)	2005-08-15	Verfahren zur herstellung von zwischenprodukten
ATE473213T1 (de)	2010-07-15	Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE299862T1 (de)	2005-08-15	Verfahren zur herstellung von ketiminen
DE50110250D1 (de)	2006-08-03	Verfahren zur herstellung von 3-aminoalkansäureestern
DE59903779D1 (de)	2003-01-23	Verfahren zur herstellung von trion-bis(oximether) derivaten sowie damit erhältliche trion-mono- und trion-bis(oximether) derivate
DE602004032089D1 (de)	2011-05-19	Verfahren zur Herstellung von 1-Methylindazol-3-Carbonsäure
DE60142962D1 (de)	2010-10-14	Verfahren zur herstellung von pestiziden verbindungen
ATE297478T1 (de)	2005-06-15	Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE260883T1 (de)	2004-03-15	Verfahren zur herstellung von atropasäureethylester
ATE264296T1 (de)	2004-04-15	Verfahren zur herstellung von cyanessigsäureestern
ATE281428T1 (de)	2004-11-15	Verfahren zur herstellung von methoxyimino- essigsäureamiden
ATE506349T1 (de)	2011-05-15	Verfahren zur herstellung von 7-chinolinyl-3,5- dihydroxyhept-6-enoat
DE50001638D1 (de)	2003-05-08	Verfahren zur herstellung von 4,6-dichlorpyrimidin
ATE394380T1 (de)	2008-05-15	Verfahren zur herstellung von (pyrimidin-2- yl)methylketonen
ATE388942T1 (de)	2008-03-15	Verfahren zur herstellung von 1-(pyrimidin-2- yl)propan-2-one derivaten
ATE227735T1 (de)	2002-11-15	Verfahren zur herstellung von 4,4- dimethyl - 3beta- hydroxypregna -8,14-dien-21- carbonsäureestern und zwischenprodukte im verfahren

Legal Events

Date	Code	Title	Description
2006-01-19	8364	No opposition during term of opposition